Results 101 to 110 of about 842,782 (192)
Alimentary Pharmacology &Therapeutics, Volume 62, Issue 6, Page 585-601, September 2025.ICI is now the first‐line therapy for unresectable HCC and has revolutionised the management of advanced HCC and is now emerging as a modality for downstaging or bridging. The ideal timing of transplant after ICI should be at least 52 days. ABSTRACT Background Ablation, surgical resection and liver transplantation (LT) are curative therapies for ...
Anand V. Kulkarni +2 more
wiley +1 more source
A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis. [PDF]
, 2017 Pyrazinamide (PZA) is an important first-line drug in all existing and new tuberculosis (TB) treatment regimens. PZA-resistance in M. tuberculosis is increasing, especially among M/XDR cases.
Catanzaro, A +7 more
core +1 more source
BMC Research Notes, 2018 Background Pulmonary nocardiosis is an opportunistic infection in an immunocompromised patient; however, often neglected in the immunocompetent patient from the diagnosis considerations.
Priyatam Khadka +3 more
doaj +1 more source
Synthesis, characterization and antitumor activity of 2-methyl-9-substituted acridines [PDF]
, 2013 In the field of antitumor DNA-intercalating agents, 9-anilinoacridines play an important role due to their antiproliferative properties. Several cancer chemotherapeutics such as amascrine and nitracrine have been developed as anticancer agents.
Kumar, Rajesh +5 more
core +2 more sources
Melioidosis: misdiagnosed in Nepal
BMC Infectious Diseases, 2019 Background Melioidosis is a life-threatening infectious disease that is caused by gram negative bacteria Burkholderia pseudomallei. This bacteria occurs as an environmental saprophyte typically in endemic regions of south-east Asia and northern Australia.
Neha Shrestha +7 more
doaj +1 more source
Molecules, 2018 Background: On account of emergence of multi- and extensively drug-resistant Mycobacterium tuberculosis (Mtb) strains, combinations of drugs with natural compounds were tested to search for antibiotic activity enhancers. In this work we studied terpenes (
Elwira Sieniawska +7 more
doaj +1 more source
A Prospective Analysis of Adverse Drug Reactions in a South Indian Hospital [PDF]
, 2009 Adverse drug reactions are a great cause of concern to the medical profession, the patients and the pharmaceutical industry. However ADR reporting and monitoring is yet to catch up in India.
Adhikari, P, Padmaja, U, Pereira, P
core
Exploring prospects of novel drugs for tuberculosis [PDF]
, 2012 Tuberculosis remains a disease with an enormous impact on public health worldwide. With the continuously increasing epidemic of drug-resistant tuberculosis, new drugs are desperately needed. However, even for the treatment of drug-sensitive tuberculosis,
Grobusch, M. P. +5 more
core +1 more source
TOWARDS NEW ANTITUBERCULAR DRUGS
, 2015 Tuberculosis, with million new cases every year, still represents a worldwide health threat. This infectious disease is caused by Mycobacterium tuberculosis and affects primarily the lungs, although it can spread to other organs.
C. Binda +3 more
semanticscholar +1 more source
Pulmonary infection by Mycobacterium riyadhense: first case report in United Arab Emirates
Frontiers in MedicineMycobacterium riyadhense is an emerging slowly growing species that belongs to the group of nontuberculous mycobacteria (NTM) with approximately 20 cases reported worldwide.
Batool A. Sawan +7 more
doaj +1 more source